Combined Biosynthetic Pathway Engineering and Storage Pool Expansion for High-Level Production of Ergosterol in Industrial Saccharomyces cerevisiae
Authors:
Open Access
- 29 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9, 681666
Abstract
Ergosterol, a terpenoid compound produced by fungi, is an economically important metabolite serving as the direct precursor of steroid drugs. Herein, ergsosterol biosynthetic pathway modification combined with storage capacity enhancement was proposed to synergistically improve the production of ergosterol in Saccharomyces cerevisiae. S. cerevisiae strain S1 accumulated the highest amount of ergosterol [7.8 mg/g dry cell weight (DCW)] among the wild-type yeast strains tested and was first selected as the host for subsequent metabolic engineering studies. Then, the push and pull of ergosterol biosynthesis were engineered to increase the metabolic flux, overexpression of the sterol acyltransferase gene ARE2 increased ergosterol content to 10 mg/g DCW and additional overexpression of a global regulatory factor allele (UPC2-1) increased the ergosterol content to 16.7 mg/g DCW. Furthermore, considering the hydrophobicity sterol esters and accumulation in lipid droplets, the fatty acid biosynthetic pathway was enhanced to expand the storage pool for ergosterol. Overexpression of ACC1 coding for the acetyl-CoA carboxylase increased ergosterol content from 16.7 to 20.7 mg/g DCW. To address growth inhibition resulted from premature accumulation of ergosterol, auto-inducible promoters were employed to dynamically control the expression of ARE2, UPC2-1, and ACC1. Consequently, better cell growth led to an increase of ergosterol content to 40.6 mg/g DCW, which is 4.2-fold higher than that of the starting strain. Finally, a two-stage feeding strategy was employed for high-density cell fermentation, with an ergosterol yield of 2986.7 mg/L and content of 29.5 mg/g DCW. This study provided an effective approach for the production of ergosterol and other related terpenoid molecules.Keywords
This publication has 55 references indexed in Scilit:
- Comparison of Sterol Import under Aerobic and Anaerobic Conditions in Three Fungal Species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiaeEukaryotic Cell, 2013
- Temporal system‐level organization of the switch from glycolytic to gluconeogenic operation in yeastMolecular Systems Biology, 2013
- Combined metabolic engineering of precursor and co-factor supply to increase α-santalene production by Saccharomyces cerevisiaeMicrobial Cell Factories, 2012
- Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisininProceedings of the National Academy of Sciences, 2012
- Overproduction of Geranylgeraniol by Metabolically Engineered Saccharomyces cerevisiaeApplied and Environmental Microbiology, 2009
- A one-step PCR-based method for rapid and efficient site-directed fragment deletion, insertion, and substitution mutagenesisJournal of Virological Methods, 2008
- Regulation of Sterol Synthesis in EukaryotesAnnual Review of Genetics, 2007
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Sterol Esterification in Yeast: A Two-Gene ProcessScience, 1996